101
|
El-Din TMG, Heldstab H, Lehmann C, Greeff NG. Biophysical Properties of Three Omega Gaps Along the Voltage Sensor S4 of Shaker Potassium Channel. Biophys J 2010. [DOI: 10.1016/j.bpj.2009.12.2834] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|
102
|
Milchert M, Spassov A, Meissner K, Nedeljkov V, Lehmann C, Wendt M, Loster BW, Mazurkiewicz-Janik M, Gedrange T, Pavlovic D. Skeletal muscle relaxants inhibit rat tracheal smooth muscle tone in vitro. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY : AN OFFICIAL JOURNAL OF THE POLISH PHYSIOLOGICAL SOCIETY 2009; 60 Suppl 8:5-11. [PMID: 20400785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 10/22/2009] [Accepted: 12/18/2009] [Indexed: 05/29/2023]
Abstract
Neuromuscular blocking drugs (NMBD) can inhibit not only nicotinic but also muscarinic (M) receptors and thereby affect not only skeletal but also smooth muscle (SM) tone. A selective postjunctional muscarinic inhibition would relax, while prejunctional inhibition of muscarinic M2 receptor might hasten SM contraction thereby increasing the risk of bronchospasm. In rat tracheal rings in vitro we evaluated the effects of cumulative concentrations of some NMBD and M receptor blocking agents for their effects on tracheal smooth muscle (TSM) tone pre-contracted with carbachol (CARB; 5 x 10(-7)M or 10(-6)M), pilocarpine (PILO; 5 x 10(-6)M), or by electrical field stimulation. The NMBDs produced relaxation in the preparations precontracted with CARB or PILO. The order of potency after CARB (10(-6)M) was (EC(50)): 4-DAMP (9.8) >atropine (9.2) >methoctramine (6.4) >pancuronium (6.0) >mivacurium (5.8) >cisatracurium (5.6) >gallamine (5.2) >rocuronium (4.8) >succinylcholine (2.9); NMBDs also partially prevented contraction elicited by the electrical field stimulation. We demonstrated that the clinically used NMBD that were examined produced rat TSM relaxation, probably by predominantly blocking postjunctional muscarinic receptors.
Collapse
|
103
|
Lehmann C, Bette S, Engele J. High extracellular glutamate modulates expression of glutamate transporters and glutamine synthetase in cultured astrocytes. Brain Res 2009; 1297:1-8. [PMID: 19728998 DOI: 10.1016/j.brainres.2009.08.070] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2009] [Revised: 08/19/2009] [Accepted: 08/24/2009] [Indexed: 12/27/2022]
Abstract
Astroglial cells clear extracellular glutamate through the glutamate transporters, GLT-1 and GLAST, and subsequently convert the incorporated glutamate into glutamine by the enzyme, glutamine synthetase (GS). Several forms of acute brain injury are associated with the increased expression of GS and the decreased expression of GLT-1 and/or GLAST, eventually leading to the accumulation of excitotoxic extracellular glutamate concentrations. Although of clinical interest, the actual trigger of these injury-related changes of glial glutamate turnover remains unknown. Our present studies provide evidence that increases in extracellular glutamate, as present in many brain injuries, are sufficient to modulate the expression of glutamate transporters and GS. Subjecting cultured cortical astrocytes to glutamate concentrations of 0.5-20 mM resulted in a 25% loss of GLT-1 and GLAST protein levels after 24 h; GLT-1 and GLAST levels maximally decreased by 40% and 75%, respectively, after 72 h. This decline was not due to astroglial cell death, since glutamate up to 50 mM did not affect the survival of cultured astrocytes within 72 h. Major astrocytic cell death, however, occurred in cultures maintained under severe (4% O(2)), but not mild (9% O(2)), hypoxia, as well as in the presence of aspartate (>or=20 mM). Glutamate at >or=1 mM induced a prolonged increase of GS expression in contrast to glutamate transporters. Neither the decline of glutamate transporter expression nor the increase in GS expression induced by high extracellular glutamate was further modulated by mild hypoxia. Whereas the stimulatory influences of glutamate on GS expression were prevented by the non-competitive NMDA receptor antagonist, MK801, the inhibitory influences on glutamate transporter expression were neither sensitive to MK801, the non-competitive mGluR5 antagonist, MTEP, nor the non-competitive AMPA receptor antagonist, GYKI52466, implying that glutamate controls glial glutamate transport by a glutamate receptor-independent mechanism.
Collapse
|
104
|
Lehmann C, Taubert D, Jung N, Fätkenheuer G, van Lunzen J, Hartmann P, Romerio F. Preferential upregulation of interferon-alpha subtype 2 expression in HIV-1 patients. AIDS Res Hum Retroviruses 2009; 25:577-81. [PMID: 19500019 DOI: 10.1089/aid.2008.0238] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Humans tailor virus-specific immune responses through modulated expression of 12 different interferon (IFN)-alpha subtypes. However, exacerbated expression of certain IFN-alpha subtypes causes immunopathology in the context of autoimmune conditions and chronic viral infections. We showed that progression to AIDS is associated with elevated expression of IFN-alpha in unstimulated peripheral blood mononuclear cells. Here, we sought to determine whether distinct IFN-alpha subtypes are involved in this phenomenon. We used quantitative RT-PCR to assess expression levels of 12 IFN-alpha subtypes in peripheral blood mononuclear cells from normal donors and HIV-1 patients at CDC stage A and stage C of the disease. Three patterns of IFN-alpha subtype expression emerged. First, IFN-alpha2 and IFN-alpha6 mRNA levels were elevated in both patient groups. Second, IFN-alpha1/13, IFN-alpha8, IFN-alpha14, IFN-alpha16, IFN-alpha17, and IFN-alpha21 were upregulated in stage C but not stage A patients. Third, expression levels of IFN-alpha4, IFN-alpha5, IFN-alpha7, and IFN-alpha10 did not change among the three groups of volunteers. Among all other subtypes, IFN-alpha2 was preferentially upregulated, showing >60-fold higher levels in stage A and >400-fold in stage C patients compared with controls, which correlated with declining CD4 counts. Our results demonstrate that distinct IFN-alpha subtypes are sequentially activated during HIV-1 infection, which may be predictive of disease progression.
Collapse
|
105
|
Lehmann C, Meuer K, Kümmerle T, Fätkenheuer G. [New antiretroviral drug classes in HIV therapy]. MMW Fortschr Med 2009; 151:64-66. [PMID: 19769081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
|
106
|
Lacroix D, Soldaini A, Lehmann C, Leflot L. WITHDRAWN: Cas radiologique du mois Radiological quiz of the month. Arch Pediatr 2009:S0929-693X(03)00652-3. [PMID: 19282156 DOI: 10.1016/j.arcped.2003.11.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.
Collapse
|
107
|
Richter J, Bittner A, Eisenhardt U, Lehmann C, Weidner K. Frühintervention bei Stress, Angst und depressiven Beschwerden in der Schwangerschaft: Wirksamkeitsnachweis mittels Cortisolmessungen im Tagesverlauf. Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1208286] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
108
|
Möller I, Schumann C, Bodelschwingh F, Lehmann C, Wirth A, Rohde A. Psychosomatik in der Praxis: Wieviel Empathie kommt an? Geburtshilfe Frauenheilkd 2009. [DOI: 10.1055/s-0029-1208288] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022] Open
|
109
|
Bittner A, Weidner K, Richter J, Müller C, Eisenhardt U, Lehmann C, Junge-Hoffmeister J, Joraschky P. Wirksamkeit eines kognitiv-behavioralen Gruppenprogramms bei Schwangeren mit erhöhten Stress-, Angst- und depressiven Symptomen. PPMP - PSYCHOTHERAPIE · PSYCHOSOMATIK · MEDIZINISCHE PSYCHOLOGIE 2009. [DOI: 10.1055/s-0029-1208227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
110
|
Lehmann C, Pavlovic D, Wilk S, Thaumüller C, Otto M, Wendt M, Felix S, Landsberger M. Inhibition of the lectin-like oxidized low-density lipoprotein receptor-1 improves intestinal microcirculation in experimental endotoxaemia. Crit Care 2009. [PMCID: PMC4084244 DOI: 10.1186/cc7522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
111
|
Thies S, Lehmann C, Kriz D, Nübling R, Mehnert A. Patientenfragebogen zur Erfassung der Reha-Motivation (PAREMO-20) – Testtheoretische Überprüfung und Validierung an einer Stichprobe von Krebspatienten unterschiedlicher Diagnosegruppen. REHABILITATION 2008; 47:308-18. [DOI: 10.1055/s-2008-1076709] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
112
|
Graf J, Michaelsen C, Schulz T, Stalke D, Lehmann C, Ruf M. Small X-ray beams for small crystals: pushing the limits of home-lab X-ray sources. Acta Crystallogr A 2008. [DOI: 10.1107/s010876730809452x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
|
113
|
Gamal El-Din TM, Grögler D, Lehmann C, Heldstab H, Greeff NG. More gating charges are needed to open a Shaker K+ channel than are needed to open an rBIIA Na+ channel. Biophys J 2008; 95:1165-75. [PMID: 18390620 PMCID: PMC2479606 DOI: 10.1529/biophysj.108.130765] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2008] [Accepted: 03/26/2008] [Indexed: 11/18/2022] Open
Abstract
This study presents what is, to our knowledge, a novel technique by means of which the ratio of the single gating charges of voltage-gated rat brain IIA (rBIIA) sodium and Shaker potassium ion channels was estimated. In the experiment, multiple tandems of enhanced green fluorescent protein were constructed and inserted into the C-terminals of Na(+) and K(+) ion channels. cRNA of Na(+) and K(+) ion channels was injected and expressed in Xenopus laevis oocytes. The two electrode voltage-clamp technique allowed us to determine the total gating charge of sodium and potassium ion channels, while a relative measure of the amount of expressed channels could be established on the basis of the quantification of the fluorescence intensity of membrane-bound channels marked by enhanced green fluorescent proteins. As a result, gating charge and fluorescence intensity were found to be positively correlated. A relative comparison of the single gating charges of voltage-gated sodium and potassium ion channels could thus be established: the ratio of the single gating charges of the Shaker potassium channel and the rBIIA sodium channel was found to be 2.5 +/- 0.4. Assuming the single channel gating charge of the Shaker K(+) channel to be approximately 13 elementary charges (well supported by other studies), this leads to approximately six elementary charges for the rBIIA sodium channel, which includes a fraction of gating charge that is missed during inactivation.
Collapse
|
114
|
Lehmann C, Koch U, Mehnert A. [Impact of the doctor-patient-communication on distress and utilization of psychosocial services among cancer patients. A review of the current literature]. Psychother Psychosom Med Psychol 2008; 59:e3-27. [PMID: 18666041 DOI: 10.1055/s-2008-1067443] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
A poor doctor-patient-communication in cancer care has negative effects on psychological well being and causes high economic costs. This review analyses the current literature on the impact of communication on distress, satisfaction and utilization of psychosocial services among cancer patients with regard to patients' communication preferences. Crucial to a successful communication seems to be the match of patients' preferences and actual physician's behaviour. However, preferences depend on various factors and can change during the illness trajectory. As preferences often remain unconsidered in everyday practice, they should be assessed repeatedly. For the lack of theoretical foundation, future research should be designed according to theoretical assumptions. In this respect we developed and suggest a model on the impact of patients' preferences on physician-patient-communication, knowledge and use of psychosocial treatment offers that particularly considers psychosocial distress of cancer patients.
Collapse
|
115
|
Birnbaum J, Klotz E, Spies CD, Mueller J, Vargas Hein O, Feller J, Lehmann C. Impact of combined C1 esterase inhibitor/coagulation factor XIII or N-acetylcysteine/tirilazad mesylate administration on leucocyte adherence and cytokine release in experimental endotoxaemia. J Int Med Res 2008; 36:748-59. [PMID: 18652771 DOI: 10.1177/147323000803600417] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
We determined the effects of combinations of C1 esterase inhibitor (C1-INH) with factor XIII and of N-acetylcysteine (NAC) with tirilazad mesylate (TM) during lipo-polysaccharide (LPS)-induced endotoxaemia in rats. Forty Wistar rats were divided into four groups: the control (CON) group received no LPS; the LPS, C1-INH + factor XIII and NAC + TM groups received endotoxin infusions (5 mg/kg per h). After 30 min of endotoxaemia, 100 U/kg C1-INH + 50 U/kg factor XIII was administered to the C1-INH + factor XIII group, and 150 mg/kg NAC + 10 mg/kg TM was administered in the NAC + TM group. Administration of C1-INH + factor XIII and NAC + TM both resulted in reduced leucocyte adherence and reduced levels of interleukin-1beta (IL-1beta). The LPS-induced increase in IL-6 levels was amplified by both drug combinations. There was no significant effect on mesenteric plasma extravasation. In conclusion, the administration of C1-INH + factor XIII and NAC + TM reduced endothelial leucocyte adherence and IL-1beta plasma levels, but increased IL-6 levels.
Collapse
|
116
|
Lehmann C, Eisner F, Engele J. Role of endothelins as mediators of injury-induced alterations of glial glutamate turnover. J Neurosci Res 2008; 86:660-7. [PMID: 17893916 DOI: 10.1002/jnr.21512] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Astroglia terminate glutamatergic neurotransmission and prevent excitotoxic extracellular glutamate concentration by clearing synaptically released glutamate through the high-affinity, sodium-dependent glutamate transporters GLT-1 and GLAST. Many brain injures are associated with the disturbed expression of glial glutamate transporters and a subsequent increase of extracellular glutamate to neurotoxic levels. We have now followed up initial hints pointing to endothelins, a family of injury-regulated peptides, as mediators of this injury-induced loss of glial glutamate transporter expression. We observed that, in line with such a role, endothelins not only act as potent inhibitors of basal and exogenously (dbcAMP)-induced expression of GLT-1 in cortical astrocytes as shown before, but likewise inhibit expression of GLT-1 or GLAST in astrocytes cultured from the diencephalon, mesencephalon, cerebellum, and spinal cord. We further demonstrate that endothelins equally inhibit GLT-1 expression in cortical slice cultures, a culture system closely resembling the in vivo situation. Although brain injuries are usually associated with an increase in the expression of the glutamate-converting enzyme glutamine synthetase, cultured cortical astrocytes maintained with endothelins showed an almost complete loss of glutamine synthetase. Interestingly, the inhibitory effects of endothelins on the expression of glutamine synthetase, but not of glutamate transporters, was overridden by high extracellular glutamate, indicating that the primarily inhibitory action of endothelins on the various components of glial glutamate turnover dissociates in the injured brain.
Collapse
|
117
|
Jung N, Owczarczyk K, Hellmann M, Lehmann C, Fatkenheuer G, Hallek M, Rubbert A. Efficacy and safety of rituximab in a patient with active rheumatoid arthritis and chronic disseminated pulmonary aspergillosis and history of tuberculosis. Rheumatology (Oxford) 2008; 47:932-3. [DOI: 10.1093/rheumatology/ken143] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
118
|
Mehnert A, Lehmann C, Schulte T, Koch U. Presence of symptom distress and prostate cancer-related anxiety in patients at the beginning of cancer rehabilitation. Oncol Res Treat 2007; 30:551-6. [PMID: 17992025 DOI: 10.1159/000108578] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
BACKGROUND A growing body of research points towards a substantial number of prostate cancer patients experiencing distress and anxiety. This study examines the frequency and character of cancer- and treatment-related problems and its association with symptom distress and prostate cancer-related anxiety in patients at the beginning of an oncological rehabilitation program. PATIENTS AND METHODS 197 prostate cancer patients who had undergone prostatectomy (92.5% participation rate) completed the Memorial Anxiety Scale for Prostate Cancer (MAX-PC), the NCCN Distress Thermometer and EORTC QLQ-C30 subscales emotional function and global quality of life. RESULTS 88% of patients report cancer- or treatment-related problems with a mean of 5 problems, and 104 patients (53%) experience distress and/or prostate cancer-related anxiety. The most prevalent symptoms are changes in urination, sexual problems, difficulties getting around, pain, fatigue and sleep problems. Emotional problems such as nervousness, worries, fears and sadness are prevalent in at least 53% of patients. Patients with distress and anxiety are confronted with a higher number and a wider range of problems and experience significantly lower levels of quality of life. CONCLUSION Findings emphasize the role of cancer rehabilitation and underline the importance of psychosocial screening measures and the provision of psychosocial support in prostate cancer patients.
Collapse
|
119
|
Koch U, Lehmann C, Morfeld M. Bestandsaufnahme und Zukunft der Rehabilitationsforschung in Deutschland. REHABILITATION 2007; 46:127-44. [PMID: 17582554 DOI: 10.1055/s-2007-973827] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
120
|
Gierschner C, Lehmann C, Feldwisch genannt Drentrup H, Nawrath J, Wohlmuth J, Schelter B, Brandt A, Timmer J, Schulze-Bonhage A. Auftreten klinischer und subklinischer intracranieller EEG-Anfallsmuster bei Patienten mit fokalen Epilepsien. KLIN NEUROPHYSIOL 2007. [DOI: 10.1055/s-2007-976346] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
121
|
Feldwisch genannt Drentrup H, Nawrath J, Gierschner C, Lehmann C, Wohlmuth J, Schelter B, Brandt A, Timmer J, Schulze-Bonhage A. Analyse der Verteilung und des Clusterings klinischer und subklinischer epileptischer Anfälle. KLIN NEUROPHYSIOL 2007. [DOI: 10.1055/s-2007-976345] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
122
|
Gründling M, Holtfreter B, Bandt C, Grunwald U, Lehmann C, Schütt C, Kuhn SO. Serum osmolality in intensive care unit patients. Acta Anaesthesiol Scand 2007; 51:383-4. [PMID: 17311642 DOI: 10.1111/j.1399-6576.2006.01254.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
123
|
Figiel M, Allritz C, Lehmann C, Engele J. Gap junctional control of glial glutamate transporter expression. Mol Cell Neurosci 2007; 35:130-7. [PMID: 17369047 DOI: 10.1016/j.mcn.2007.02.009] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2006] [Revised: 02/06/2007] [Accepted: 02/08/2007] [Indexed: 11/24/2022] Open
Abstract
The uptake of glutamate into astroglia is the predominant mechanism to terminate glutamatergic neurotransmission and to prevent neurotoxic extracellular glutamate concentrations. Here, we show that uncoupling cultured cortical astrocytes with the gap junction blocker, propofol, or the Cx43 mimetic peptide, Gap27, inhibits the expression of GLT-1, the major glutamate transporter subtype in the cortex. The dependence of GLT-1 expression on gap junctions was further confirmed by the use of astrocytes in which either the expression of Cx43, the major astrocytic gap junction protein, was inhibited by RNA interference or which were derived from animals carrying an astrocyte-specific deletion of the Cx43 gene. In both cases, reduced astrocytic coupling was associated with a pronounced decline in GLT-1 expression. Finally, a luciferase reporter gene assay demonstrated that blockade of gap junctions/connexins suppressed transcriptional activity of GLT-1 promoter. These observations unravel a previously unrecognized role of gap junctions in the control of glial glutamate transport.
Collapse
|
124
|
Zuntz N, Lehmann C. Remarks on the Chemistry of respiration in the Horse during Rest and Work. J Physiol 2007; 11:396-8. [PMID: 16991953 PMCID: PMC1514233 DOI: 10.1113/jphysiol.1890.sp000338] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
|
125
|
Bader R, Winkel S, Kameke B, Hoffmann B, Hansen L, Lehmann C, Stripling JH, Awwad N, Riess FC. Survival and midterm results of octogenarians undergoing isolated coronary revascularization: Is there a benefit of using bilateral internal mammary artery grafting? Thorac Cardiovasc Surg 2007. [DOI: 10.1055/s-2007-967563] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|